Antidiuretic Drugs Market Forecast Information: By Type (Vasopressin, Desmopressin, Oxytocin, others), By Indication (Diabetes Insipidus, Hemophilia, Hypertension, others), By End Users (Hospitals, Clinics, Pharmaceutical Companies, others) - Global Forecast till 2023
The Global Antidiuretic Drugs Market Forecast is expected to show sharp growth over the forecast period. Increasing prevalence of diabetes and demand for new drugs for its treatment are the key factor for the market growth. Rising geriatric population with diabetes insipidus also drive the market growth. Also, use of antidiuretic drugs for the treatment of hypertension is found to be increasing across the globe.
The Global Antidiuretic Drugs Market Forecast is expected to grow at a CAGR of 9.7% during the forecast period and is estimated to reach USD 180 million by 2023.
Taste the Market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Antidiuretic Drugs Market Forecast research report–Global forecast till 2023.”
Major Players in Antidiuretic Drugs Market Forecast
Some of the key players in the global market are Par Sterile Products, LLC (U.S.), ADH Health (U.S.), Azevan Pharmaceuticals, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Otsuka Holdings Co. Ltd (Japan), Taj Pharmaceuticals Limited (India) and ALLERGAN (U.S.).
Browse Complete Report: https://www.marketresearchfuture.com/reports/antidiuretic-drugs-market-4306
The global Antidiuretic Drugs Market Forecast consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas dominate the global Antidiuretic Drugs Market Forecast. It comprises of two regions namely North America and South America. The market in the American region is driven by the rising prevalence of diabetes insipidus. Increase in geriatric population with diabetes and hypertension also contribute to the market growth.
In Europe, increasing adoption of new drugs for the treatment of diabetes insipidus, and availability of funds for research and development.
Asia Pacific is the fastest growing and potential market for the antidiuretic drugs treatment, whose growth is attributed to the increase in the awareness about the use of antidiuretics for the treatment and its side effects. Expansion of healthcare system in developing countries in Asia Pacific also favors the market growth.
The Middle East & Africa is expected to witness steady growth due to rising demand for primary healthcare services.
The global Antidiuretic Drugs Market Forecast is segmented on the basis of types, which includes vasopressin, desmopressin, oxytocin, and others. Other types of antidiuretic drugs are argipressin, lypressin, ornipressin and terlipressin. On the basis of indication, the market is segmented into diabetes insipidus, hemophilia, hypertension, and others. Diabetes insipidus is further sub-segmented into central diabetes insipidus, nephrogenic diabetes insipidus, dipsogenic diabetes insipidus and gestational diabetes insipidus. Other indications are polyuria, polydipsia and enuresis. On the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies, and others.